Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 652

1.

Beneficial effects of short-term vasopressin infusion during severe septic shock.

Patel BM, Chittock DR, Russell JA, Walley KR.

Anesthesiology. 2002 Mar;96(3):576-82.

PMID:
11873030
2.

Low-dose vasopressin in the treatment of vasodilatory septic shock.

Malay MB, Ashton RC Jr, Landry DW, Townsend RN.

J Trauma. 1999 Oct;47(4):699-703; discussion 703-5.

PMID:
10528604
3.

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators.

N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.

4.

Effects of short-term fenoldopam infusion on gastric mucosal blood flow in septic shock.

Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Coluzzi F, Vernaglione E, Pelaia P, Pietropaoli P.

Anesthesiology. 2004 Sep;101(3):576-82.

PMID:
15329581
5.

Effects of continuous vasopressin infusion in patients with septic shock.

Obritsch MD, Jung R, Fish DN, MacLaren R.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. Epub 2004 Jun 3.

PMID:
15178740
6.

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.

Pharmacotherapy. 2004 Aug;24(8):1002-12.

PMID:
15338849
7.

High-dose vasopressin is not superior to norepinephrine in septic shock.

Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A.

Crit Care Med. 2003 Nov;31(11):2646-50.

PMID:
14605537
8.

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.

Albanèse J, Leone M, Delmas A, Martin C.

Crit Care Med. 2005 Sep;33(9):1897-902.

PMID:
16148457
9.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
10.

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):13-20.

PMID:
14707555
11.

Comparison of systemic and regional effects of dobutamine and dopexamine in norepinephrine-treated septic shock.

Levy B, Nace L, Bollaert PE, Dousset B, Mallie JP, Larcan A.

Intensive Care Med. 1999 Sep;25(9):942-8.

PMID:
10501749
12.

Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.

Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T.

Crit Care Med. 1999 Sep;27(9):1708-13.

PMID:
10507587
13.

Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock.

Minneci PC, Deans KJ, Banks SM, Costello R, Csako G, Eichacker PQ, Danner RL, Natanson C, Solomon SB.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2545-54. Epub 2004 Aug 19.

14.

Vasopressin decreases intestinal mucosal perfusion: a clinical study on cardiac surgery patients in vasodilatory shock.

Nygren A, Thorén A, Ricksten SE.

Acta Anaesthesiol Scand. 2009 May;53(5):581-8. doi: 10.1111/j.1399-6576.2008.01900.x. Epub 2009 Feb 23.

PMID:
19239407
15.

The long-term survival rate of catecholamine-resistant septic shock in Japanese patients who received vasopressin therapy.

Sawa N, Ubara Y, Katori H, Hoshino J, Suwabe T, Takemoto F, Uchida N, Masuoka K, Wake A, Taniguchi S, Takaichi K.

Clin Nephrol. 2009 Aug;72(2):129-36.

PMID:
19640370
16.

Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.

Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ; Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.

Crit Care Med. 2009 Mar;37(3):811-8. doi: 10.1097/CCM.0b013e3181961ace.

PMID:
19237882
17.

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.

Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd.

Crit Care Med. 2001 Mar;29(3):487-93.

PMID:
11373409
18.

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.

Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10.

19.

Low-dose vasopressin in the treatment of septic shock in sheep.

Sun Q, Dimopoulos G, Nguyen DN, Tu Z, Nagy N, Hoang AD, Rogiers P, De Backer D, Vincent JL.

Am J Respir Crit Care Med. 2003 Aug 15;168(4):481-6. Epub 2003 Jun 5.

PMID:
12791578
20.

The cardiopulmonary effects of vasopressin compared with norepinephrine in septic shock.

Gordon AC, Wang N, Walley KR, Ashby D, Russell JA.

Chest. 2012 Sep;142(3):593-605. doi: 10.1378/chest.11-2604.

PMID:
22518026

Supplemental Content

Support Center